A study to evaluate the reduced monocyte activation and infliximab therapy response in patients with ulcerative colitis.
Phase of Trial: Phase IV
Latest Information Update: 18 Dec 2015
At a glance
- Drugs Infliximab (Primary)
- Indications Ulcerative colitis
- Focus Pharmacodynamics
- 18 Dec 2015 Status changed from not stated to completed.
- 18 Dec 2015 New trial record